Breaking: Lilly Partners With US Firms to Make Mounjaro, Boost Supply Eli Lilly, now Cagrillintide USA manufacturer the world's most valuable healthcare company by market capitalization, has seen its shares soar 62.5% this year due to high demand for their diabetes drug Mounjaro. The company plans to invest $5.3 billion to expand production cap